{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-013240","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.908114+00:00","generated_at":"2026-05-15T08:42:52.761077+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"TELO shareholders approve acquisition of Teli Pharma and increase share reserve to 11.5M","bullets":["Acquisition of Teli Pharmaceuticals approved; issuance of >20% new shares authorized.","2023 Omnibus Incentive Plan amended: share reserve increased from 6.5M to 11.5M shares and repricing allowed.","Bylaws amended to reduce quorum requirement to one-third of outstanding shares.","Directors elected: Erez Aminov, Matthew Whalen, Edward MacPherson, Matthew Del Giudice.","Ratification of Salberg & Company as independent auditor for FY 2025 approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-013240","json":"https://secwatch.observer/filing/0001493152-26-013240.json","markdown":"https://secwatch.observer/filing/0001493152-26-013240.md","text":"https://secwatch.observer/filing/0001493152-26-013240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226013240/0001493152-26-013240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226013240/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:42:52.761077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17e2fb1b157d55ca00a5aaf9d848c06bc9280d40","claim":"Telomir Pharmaceuticals, Inc.: Reduced quorum requirement for shareholder meetings to one-third (effective 2026-03-23).","evidence_excerpt":"the Company’s shareholders approved an amendment to the Bylaws of the Company to reduce the amount required for a quorum for an action by the Company’s shareholders adopted in a meeting to one-third.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226013240/0001493152-26-013240-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-03-23"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}